News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
PCI Highlights mRNA Innovation at JPM
On January 9th, 2023 PCI was proud to present a star-studded program entitled “The Future of mRNA Technology” at Wharton San Francisco during the JP Morgan Healthcare Conference.
Microrobotics for Precision Biofilm Diagnostics and Treatment
Koo and Steager's magnetic, scalable, tether-free robotic devices can be used for diagnostics via retrieval and sampling of biofilms associated with infectious diseases as well as the assessment of bi
Three Penn Spinouts Made Philadelphia Business Journal’s PHLInno List of Top Philadelphia Startups to Watch in 2023
Exciting news for three innovative Penn spinouts.
Katalin Karikó and Drew Weissman named to the National Inventors Hall of Fame
Karikó and Weissman were named to the National Inventors Hall of Fame for their mRNA research which made covid-19 vaccines possible.
Penn I-Corps Fall 2022 Cohort
In Fall 2022, ten teams participated in the Penn I-Corps Program, representing the Schools of Arts and Sciences, Engineering, Medicine, Veterinary Medicine, and Business.
Penn Startups Raising Money in 2023
There are a wide range of Penn spinouts across industries that are working on innovative and transformative products and projects. This is a list of Penn startups currently raising money in 2023.
Exyn Technologies Secures $35M in Series B Funding
Penn spinout Exyn Technologies, a pioneer in multi-platform robotic autonomy for complex, GPS-denied environments, had a $35 million Series B round at the end of 2022.
Penn’s Abramson Cancer Center Presents New Cancer Research at 2022 American Society of Hematology (ASH) Annual Meeting
Researchers from Penn’s Abramson Cancer Center presented the preliminary results of an ongoing Phase I clinical trial for a novel CAR T therapy to be used after cancer.
Penn Researchers Work On Reducing CO2 Emissions by Repurposing Waste from Industrial Mines
Peter Psarras, a research assistant professor in chemical and biomolecular engineering, and his colleagues are repurposing waste from industrial mines.
Penn spinout Peroxitech raises $25M to advance novel drug to treat acute lung injury
Penn spinout Peroxitech raised $25M to further develop its novel drug candidate, PIP-2.